Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03260738
Other study ID # 29BRC17.0084
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 23, 2017
Est. completion date April 2, 2019

Study information

Verified date April 2020
Source University Hospital, Brest
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The objective of KERAAL technological project is to create a new intelligent robot which allows a humanoid robot to record then to show and to follow the progress of rehabilitation sessions proposed by a physiotherapist to a patient, the latter being able to practice without the physiotherapist. The final objective is to stimulate and increase the overseen time of rehabilitation. Poppy robot was chosen as it is able to realize all kind of movements notably movements of the spine with 5 degrees of freedom associated to the several levels of the spine. It will allow to address the population included in the protocol. RCOOL study tries to validate this prototype device as tool of rehabilitation.

The main objective is the feasibility of the supervision by a humanoid robot of a succession of rehabilitation exercises.

RCOOL study is a randomized clinical trial checked under single-blind condition to compare two rehabilitation strategies, one with exercises executed by the patients and supervised by Poppy and the other one with usual rehabilitation protocol.


Recruitment information / eligibility

Status Completed
Enrollment 31
Est. completion date April 2, 2019
Est. primary completion date October 26, 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria:

- Chronic Low back pain (more than 6 months)

- Patient who has completed an outpatient rehabilitation program with at least 20 spine-centric sessions

- Inclusion in a low back pain rehabilitation program in an inpatient our outpatient unit.

- Adult between 18 and 70 years old

- Patient affiliated to French social security system

- Patient having signed an informed consent of participation for research

Exclusion Criteria:

- Symptomatic low back pain (identified medical etiology)

- Isolated sciatica, whatever the cause

- Cruralgia

- Chronic widespread pain

- Age lower than 18 and higher than 70

- Unfit of agreeing or refusing to participate in the study

- Unstable medical situation preventing the continuous realization of a program of at least 4 weeks

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Rehabilitation program with Poppy robot
Patient with a chronic low back pain. Usual 3 hours rehabilitation daily program, 5 days a week, 3 weeks. Among those 3 hours, patients receive 30 minutes of physical exercises dedicated to mobility of the spine supervised by robot Poppy.
Other:
Usual rehabilitation program
Patient with a chronic low back pain. Usual 3 hours rehabilitation daily program, 5 days a week, 3 weeks.

Locations

Country Name City State
France CHRU de Brest Brest
France Fondation ILDYS - Service de MPR de l'appareil locomoteur de PERHARIDY Roscoff

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Brest

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Average time of the daily physical activity Each therapist note the time of each physical activity session with the usually breaks. The time of kinesitherapy included the activity supervised by poppy will allow to evaluate the prototype device feasibility. Day 0 to Week 4
Secondary Visual Analog Scale (EVA) of lumbar pain Day 0, Week 4 and Month 6
Secondary Roland-Morris questionnaire Day 0, Week 4 and Month 6
Secondary Dallas questionnaire Day 0, Week 4 and Month 6
Secondary Fear Avoidance and Belief Questionnaire (FABQ) Day 0, Week 4 and Month 6
Secondary Number of adverse events Day 0 to Day 90
Secondary Acceptability questionnaire Week 4 and Month 6
Secondary Number of exercises done during rehabilitation supervised by robot Poppy (30 minutes each day for 4 weeks) Day 0 to Week 4
See also
  Status Clinical Trial Phase
Completed NCT03243084 - Transcranial Alternating Current Stimulation in Back Pain- Pilot Sudy N/A
Suspended NCT04735185 - Stem Cells vs. Steroids for Discogenic Back Pain N/A
Completed NCT03162952 - RAND Center of Excellence for the Study of Appropriateness of Care in CAM
Completed NCT03240146 - Pulsed Shortwave Therapy Treatment for Chronic Musculoskeletal Low Back Pain N/A
Completed NCT05282589 - Lumbopelvic Manipulation Effects on Fatigue in Chronic Low Back Pain Patients N/A
Completed NCT03637998 - Physical Activity on Neurophysiologic Gene Expression Profiles of Chronic Low Back Pain N/A
Recruiting NCT02289170 - Clinical Study to Evaluate the Safety and Efficacy of Heating and Cooling Combination Therapeutic Device(OCH-S100) N/A
Active, not recruiting NCT01944163 - The IMPACT of a Referral Model for Axial Spondyloarthritis in Young Patients With Chronic Low Back Pain N/A
Completed NCT02231554 - Feldenkrais vs Back School for Treating Chronic Low Back Pain: a Randomized Controlled Trial N/A
Recruiting NCT02063503 - Identification of Prognostic Indicators for Rehabilitation in Chronic Nonspecific Low Back Pain Patients N/A
Completed NCT01704677 - Lumbar Disc Prosthesis Versus Multidisciplinary Rehabilitation; 8-year Follow-up N/A
Terminated NCT01620775 - MR(Magnetic Resonance) Imaging of Neurotransmitters in Chronic Pain N/A
Completed NCT01490905 - A Double Blind Placebo Study to Determine the Effectiveness of Theramine on the Management of Chronic Back Pain Phase 4
Completed NCT01177241 - Cytochrome P450 Pharmacokinetic DDIs Among Patients With Chronic Low Back Pain Taking Opioids N/A
Completed NCT01177254 - Exposure to Potential Cytochrome P450 Pharmacokinetic Drug-Drug Interactions Among Osteoarthritis Patients: Incremental Risk of Multiple Prescriptions N/A
Completed NCT01177280 - Prevalence of Potential Cytochrome P450 Pharmacokinetic Incident Drug-Drug Interactions Among Chronic Low Back Pain Patients Taking Opioid Analgesics and Associated Economic Outcomes N/A
Completed NCT00984815 - Safety Study of HZT-501 in Patients Who Require Long-Term Daily Non-steroidal Anti-inflammatory Drug Treatment Phase 3
Completed NCT00763321 - Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP) Phase 3
Completed NCT00761150 - Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP) Phase 3
Completed NCT00767806 - A Study for Patient With Chronic Low Back Pain Phase 3